Table 2.
NR3C1 Assay Name (CpG Positions) |
Primers* | Sequence to analyze (converted) Chromosome location |
---|---|---|
1D (8) |
PCR forward GGATAAGAGGTTTGTTGAAAGTTTATT PCR reverse Biotin-ACTCCCCCTACTCTAACAT Forward sequencing 1D AGGAAGGAAGGTTTAGGT |
5:142785061-142785008 TATTYGG/AYGATYGYGAATTTTTGTTAAGATGKTGGTYGYGGGGAYGGGTTGGYGATATTGTATTTTATTAAGATGG |
1F 3 pyrosequencing assays (19) |
PCR forward TTTTTTTTTTGAAGTTTTTTT PCR reverse Biotin-CCCCCAACTCCCCAAAAA Forward sequencing F0 GAGGAGTTTAGGTTTTTGTG Forward sequencing F1 GAGTGGTTTGGAGT Forward sequencing F2 AGAAAAGAATTGGAGAAATT |
sequence F0 (CpG 1-6) 5:142783720-142783676 GTTYGTTYGTTGTTATTYGTAGGGGTATTGGYGG/AYGTTTGTYGTTAAGGGGTAGAG sequence F1 (CpG 7–11) 5:142783640-142783588 YGYGGAGTTGGGYGGGGGYGGGAAGGAGGTAGYGAGAAAAGAAATTGGAGAAA sequence F2 (CpG 12–19) 5:142783585-142783501 YGGTGGTTTTTTTAAYGTYGTTTTAGAGAGATTAGGTYGGTTTTYGTYGTTGTYGTYGTTGTTTTTTTTTTTGGGGAGTTGGGGG |
1H (9) |
PCR forward AGGGGTTTTTTTTTTATTTATGGAGA PCR reverse Biotin-CCCACTCCCCCAAACTAATAAAAATTTAT Forward sequencing 1H GAGAGGTTTTTTTGTTAGAGGTA |
5:142782749-142782607 AGAAGYGAGGYGGRAGGGGGTYGGGGYGYGTTYGTTTTTTYGAGGTGTYGTTGGGATYGGAGATAA |
Primer sequences are given 5′ to 3′ direction